Pro Health Tips
Sunday, 29 September 2019
Inhibitors That Improve Overall Survival in Advanced Breast Cancer Discovered
Treatment with the CDK4/6 inhibitor ribociclib plus fulvestrant significantly improves overall survival in postmenopausal patients with HR+ HER2- advanced breast cancer.
from Medindia Health News https://ift.tt/2nESuA7
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Treatment with the CDK4/6 inhibitor ribociclib plus fulvestrant significantly improves overall survival in postmenopausal patients with HR+ HER2- advanced breast cancer.
No comments:
Post a Comment